These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27273676)

  • 1. Effects of 14 Versus 21 Days of Nimodipine Therapy on Neurological Outcomes in Aneurysmal Subarachnoid Hemorrhage Patients.
    Cho S; Bales J; Tran TK; Korab G; Khandelwal N; Joffe AM
    Ann Pharmacother; 2016 Sep; 50(9):718-24. PubMed ID: 27273676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nimodipine after aneurysmal subarachnoid hemorrhage: Fourteen-day course for patients that meet criteria for early hospital discharge.
    Sokolowski JD; Chen CJ; Soldozy S; Mastorakos P; Burke RM; Nguyen JM; Myers KM; Kalani MYS; Park MS
    Clin Neurol Neurosurg; 2021 Jan; 200():106299. PubMed ID: 33092929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nimodipine Dose Reductions in the Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage.
    Sandow N; Diesing D; Sarrafzadeh A; Vajkoczy P; Wolf S
    Neurocrit Care; 2016 Aug; 25(1):29-39. PubMed ID: 26690937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of an abbreviated course of nimodipine in patients with good-grade aneurysmal subarachnoid hemorrhage.
    Toyota BD
    J Neurosurg; 1999 Feb; 90(2):203-6. PubMed ID: 9950489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor Utilization of Nimodipine in Aneurysmal Subarachnoid Hemorrhage.
    Hajizadeh Barfejani A; Rabinstein AA; Wijdicks EFM; Clark SL
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2155-2158. PubMed ID: 31103551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized outcome study of enteral versus intravenous nimodipine in 171 patients after acute aneurysmal subarachnoid hemorrhage.
    Soppi V; Karamanakos PN; Koivisto T; Kurki MI; Vanninen R; Jaaskelainen JE; Rinne J
    World Neurosurg; 2012 Jul; 78(1-2):101-9. PubMed ID: 22120252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)].
    Hänggi D; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Macdonald RL;
    Neurocrit Care; 2019 Feb; 30(1):88-97. PubMed ID: 30014184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Early Versus Late Intravenous Followed by Oral Nimodipine Treatment on the Occurrence of Delayed Cerebral Ischemia Among Patients With Aneurysm Subarachnoid Hemorrhage.
    Samseethong T; Suansanae T; Veerasarn K; Liengudom A; Suthisisang C
    Ann Pharmacother; 2018 Nov; 52(11):1061-1069. PubMed ID: 29783859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of Oral and Intra-arterial Nimodipine Administration After Aneurysmal Subarachnoid Haemorrhage - A Single-centre Study.
    Ehrlich G; Kirschning T; Wenz H; Hegewald AA; Neumaier-Probst E; Seiz-Rosenhagen M
    In Vivo; 2019; 33(6):1967-1975. PubMed ID: 31662526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    van den Bergh WM; Mees SM; Rinkel GJ
    Neurosurgery; 2006 Nov; 59(5):E1152; author reply E1152. PubMed ID: 17143226
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America.
    Haley EC; Kassell NF; Apperson-Hansen C; Maile MH; Alves WM
    J Neurosurg; 1997 Mar; 86(3):467-74. PubMed ID: 9046304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is intra arterial nimodipine really beneficial in vasospasm following aneurysmal subarachnoid haemorrhage?
    Goel R; Aggarwal A; Salunke P; Kumar A; Chhabra R
    Br J Neurosurg; 2016 Aug; 30(4):407-10. PubMed ID: 26999260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dangers of outpatient nimodipine use after spontaneous subarachnoid hemorrhage in accordance with the Comprehensive Stroke Center guidelines.
    Chen CJ; Turnage C; Sokolowski JD; Kumar JS; Kalani MY; Park MS
    J Clin Neurosci; 2018 Jun; 52():151-152. PubMed ID: 29656002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness comparisons of drug therapies for postoperative aneurysmal subarachnoid hemorrhage patients: network meta‑analysis and systematic review.
    Yu W; Huang Y; Zhang X; Luo H; Chen W; Jiang Y; Cheng Y
    BMC Neurol; 2021 Jul; 21(1):294. PubMed ID: 34311705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of nimodipine monotherapy and combined treatment with ketamine and lignocaine in aneurysmal subarachnoid haemorrhage.
    Langelaar G; Leeuwenkamp OR; Sterkman LG; Torreman M; Hesselink JM
    J Int Med Res; 1996; 24(5):425-32. PubMed ID: 8895046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage.
    Carlson AP; Hänggi D; Wong GK; Etminan N; Mayer SA; Aldrich F; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Bleck T; Grubb R; Miller M; Suarez JI; Proskin HM; Macdonald RL;
    Stroke; 2020 Apr; 51(4):1142-1149. PubMed ID: 32138631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage.
    Hänggi D; Etminan N; Macdonald RL; Steiger HJ; Mayer SA; Aldrich F; Diringer MN; Hoh BL; Mocco J; Strange P; Faleck HJ; Miller M
    Neurocrit Care; 2015 Oct; 23(2):274-84. PubMed ID: 25678453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In brief: nimodipine oral solution (Nymalize).
    Med Lett Drugs Ther; 2013 Aug; 55(1423):68. PubMed ID: 23959389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.